Organoids are three‐dimensional (3D) miniaturized versions of organs or tissues that are
derived from cells with stem potential and can self‐organize and differentiate into 3D cell …

Nowadays, the diagnosis and treatment system of malignant tumors has increasingly tended
to be more precise and personalized. And the existing tumor models are still unable to fully …

Despite advancements in treatment protocols, cancer is one of the leading cause of deaths
worldwide. Therefore, there is a need to identify newer and personalized therapeutic targets …

Simple Summary Further investigation into the molecular mechanisms of chemotherapy
resistance in pancreatic cancer is crucial for improving the prognosis of pancreatic cancer …

Gastric cancer ranks the fifth most common and third leading cause of cancer‐related deaths
worldwide. Alterations in the RTK/MAPK, WNT, cell adhesion, TP53, TGFβ, NOTCH, and …

Pancreatic adenocarcinoma (PDAC) is predicted to become the second leading cause of
cancer deaths by 2030 and this is mostly due to therapy failure. Limited treatment options …

Simple Summary Radiotherapy is part of the standard of care for many solid tumors. In
pancreatic ductal adenocarcinoma (PDAC), good responses to radiotherapy can only be …

Drug resistance that affects patients universally is a major challenge in cancer therapy. The
development of drug resistance in cancer cells is a multifactor event, and its process …

Introduction Pancreatic ductal adenocarcinoma presents with a dismal prognosis.
Personalized therapy is urgently warranted to overcome the treatment limitations of the 'one …

Purpose: To assess the prognostic value of copper-dependent genes, copper-dependent-
related genes (CDRG), and CDRG-associated immune-infiltrating cells (CIC) for pancreatic …